BCI Affects and Survivorship

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.
July 25, 2018

New Clinical Trial Data in Advanced Melanoma Presented at ASCO 2018: How Will it Change How You Practice?

Dr Sanjiv Agarwala talks about exciting new results presented at ASCO 2018 in melanoma, including the durability of anti–PD-1 therapy in providing 40% overall survival at 5 years, updates on adjuvant therapy showing superiority of anti–PD-1 over anti–CTLA-4, and new results in combining immunotherapies.

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.